NCT05578950View on ClinicalTrials.gov

Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Onychomycosis
Interventions
DRUG

itraconazole

100 mg two capsules of itraconazole were givev twice daily to 50 patients in group A for one week per month . baseline LFTs were also monitered

DRUG

terbinafine

one 250 mg tablet of terbinafine were given once daily to 50 patients in group B for 12 weeks continously

Trial Locations (1)

22020

Cmh Abbottabad, Abbottābād

All Listed Sponsors
lead

Combined Military Hospital Abbottabad

OTHER